long half-life and large variability [Regulatives / Guidelines]

posted by martin  – Austria, 2020-07-29 22:49 (423 d 10:44 ago) – Posting: # 21801
Views: 1,867

dear ElMaestro,

Thank you for your swift reply and sharing your thoughts.

There are two types of covariates (type 1: continous = subject specfic values; and type 2: categorical variable with a few levels).

At the first glance a different regulatory pathway might be worth considering based on a PK or exposure similarity evalulation as in such a case there could be more flexibility regarding acceptance of statistical models used to test for equivalence in PK metrics.

Happy to get your thoughts on this idea.

best regards


Complete thread:

 Admin contact
21,700 posts in 4,538 threads, 1,542 registered users;
online 10 (0 registered, 10 guests [including 2 identified bots]).
Forum time: Sunday 09:33 CEST (Europe/Vienna)

A central lesson of science is that to understand complex issues
(or even simple ones), we must try to free our minds of dogma and
to guarantee the freedom to publish, to contradict, and to experiment.
Arguments from authority are unacceptable.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz